Over the past twenty years combination chemotherapy has continued to produce small survival gains for patients with SCLC. We enter the next century enthusiastic about the array of new chemotherapeutic agents to evaluate and fascinated by the biological agents with the hope of achieving dramatic improvements in survival for our patients with SCLC.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Kelly, K. (2001). Treatment of extensive stage small cell lung cancer. Cancer Treatment and Research. https://doi.org/10.1007/978-1-4615-1589-0_10